Borvo Medical
Generated 5/9/2026
Executive Summary
Borvo Medical is a private medical device company based in San Jose, California, founded in 2016. The company specializes in the treatment of subdural hematomas with its proprietary Endoport Vacuum Assisted Collection (EVAC) system. The EVAC platform includes two designs—the EVAC Ergo and EVAC Classic—both engineered for minimally invasive drainage of subdural hematomas. These devices are designed by and for neurointerventional surgeons, aiming to improve patient outcomes through efficient, safe, and ergonomic clot evacuation. Subdural hematomas are a common neurosurgical emergency, particularly in the elderly and trauma patients, and current drainage methods often involve burr holes or craniotomies with limited evacuation efficiency. Borvo's EVAC technology addresses this gap by providing a vacuum-assisted approach that may reduce procedure time and improve clot removal completeness. While the company remains in a relatively early stage, with no disclosed funding rounds or regulatory approvals, its innovative product line targets a clear clinical need in a large and growing market.
Upcoming Catalysts (preview)
- TBDFDA 510(k) clearance for EVAC system40% success
- TBDFirst-in-human clinical study initiation30% success
- TBDStrategic partnership or distribution agreement20% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)